Adult Rhabdomyosarcoma (DBCOND0028669)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT01222715	Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma	Bevacizumab Cyclophosphamide Menthol Sirolimus Temsirolimus Vinorelbine	treatment	2	completed
NCT00354835	Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma	Camptothecin Cyclophosphamide Dactinomycin Irinotecan Sulfate ion Vincristine	treatment	3	completed
NCT00720174	Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma	Cixutumumab Doxorubicin	treatment	1	completed
NCT00659360	AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma	Saracatinib	treatment	2	completed
NCT00003292	S9624 Ifosfamide in Treating Patients With Meningeal Tumors	Ifosfamide	treatment	2	terminated
NCT00831844	Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors	Cixutumumab	treatment	2	completed
NCT01586104	Intensity-Modulated Radiation Therapy in Treating Younger Patients With Lung Metastases	No drug interventions	treatment	Not Available	completed
NCT01055314	Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma	Beta-D-Glucose Camptothecin Cixutumumab Cyclophosphamide Dactinomycin Doxorubicin Etoposide Ifosfamide Irinotecan Temozolomide Vincristine	treatment	2	completed
NCT00331643	Ixabepilone in Treating Young Patients With Refractory Solid Tumors	Ixabepilone Patupilone	treatment	2	completed
NCT01532687	Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma	Gemcitabine Pazopanib	treatment	2	completed
NCT00638898	Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor	Busulfan Filgrastim Melphalan Topotecan	treatment	1	active_not_recruiting
NCT01154452	Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma	RG-4733 Vismodegib	treatment	1 / 2	completed
NCT00003958	Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma	Cyclophosphamide Dactinomycin Filgrastim Sargramostim Sulfate ion Topotecan Vincristine	treatment	3	completed
NCT00112463	Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma	Romidepsin	treatment	2	completed
NCT00075582	Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Cyclophosphamide Dactinomycin Sulfate ion Vincristine	treatment	3	completed
NCT00919269	Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	No drug interventions	Not Available	Not Available	completed
NCT01668095	Biomarkers in Patients With Advanced Rhabdomyosarcoma	No drug interventions	Not Available	Not Available	completed